These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 12750435)
1. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells. Bañuelos A; Reyes E; Ocadiz R; Alvarez E; Moreno M; Monroy A; Gariglio P J Pharmacol Exp Ther; 2003 Aug; 306(2):671-80. PubMed ID: 12750435 [TBL] [Abstract][Full Text] [Related]
2. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
3. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells. Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633 [TBL] [Abstract][Full Text] [Related]
4. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297 [TBL] [Abstract][Full Text] [Related]
5. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Munagala R; Kausar H; Munjal C; Gupta RC Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835 [TBL] [Abstract][Full Text] [Related]
6. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367 [TBL] [Abstract][Full Text] [Related]
7. A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells. Allen KL; Tschantz DR; Awad KS; Lynch WP; DeLucia AL Mol Carcinog; 2007 Jul; 46(7):564-75. PubMed ID: 17393435 [TBL] [Abstract][Full Text] [Related]
8. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
9. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281 [TBL] [Abstract][Full Text] [Related]
10. Functional p53 protein in human papillomavirus-positive cancer cells. Butz K; Shahabeddin L; Geisen C; Spitkovsky D; Ullmann A; Hoppe-Seyler F Oncogene; 1995 Mar; 10(5):927-36. PubMed ID: 7898934 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7. Kamradt MC; Mohideen N; Krueger E; Walter S; Vaughan AT Br J Cancer; 2000 May; 82(10):1709-16. PubMed ID: 10817508 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines. Mantovani F; Banks L Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351 [TBL] [Abstract][Full Text] [Related]
13. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. Koivusalo R; Krausz E; Helenius H; Hietanen S Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516 [TBL] [Abstract][Full Text] [Related]
15. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells. Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130 [TBL] [Abstract][Full Text] [Related]
17. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033 [TBL] [Abstract][Full Text] [Related]
18. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Pim D; Massimi P; Banks L Oncogene; 1997 Jul; 15(3):257-64. PubMed ID: 9233760 [TBL] [Abstract][Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
20. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Pim D; Banks L Oncogene; 1999 Dec; 18(52):7403-8. PubMed ID: 10602499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]